|
|
GENTAUR
 +32 1658 9045
or
0032 (0)16 41 44 07
 +32 1650 9045
[email protected]
Av. de l' Armιe 68
B-1040 Brussels
BELGIUM
France
tel 01 43 25 01 50
fax01 43 25 01 60
9, rue Lagrange
75005 Paris
Italia
tel 02 36 00 65 93
fax 02 36 00 65 94
20135 Milano
Deutschland
tel +32 1658 9045
fax +32 1650 9045
Polska
Tel 058 710 33 44
Fax 00 32 16 50 90 45
ul. Grunwaldzka 88A/2
81-771 Sopot
日本
tel +81 78 386 0860
fax +81 78 306 0296
Minaatojimaminami-manchi
Chuo-ku, Kobe
065-0047
Φsterreich
+43720880899
Canada Montreal
+15149077481
Českα republika Praha
+420246019719
Danmark
+4569918806
Finland Helsset
+358942419041
Ελλάς Αθήνα
+302111768494
Magyarorszαg Budapest
+3619980547
Ireland Dublin
+35316526556
Luxembourg
+35220880274
Nederland
+31208080893
Norge Oslo
+4721031366
Polska Warszawa
+48223988221
Sverige Stockholm
+46852503438
Schweiz Zόri
+41435006251
US New York
+17185132983
Other Countries
0032 (0)16 41 44 07
|
|
| |
|
3P01 |
Angiotensin Acetate |
58-49-1 |
|
3P02 |
Bivalirudin Trifluoroacetate |
128270-60-0 |
|
3P03 |
Desmopressin Acetate |
|
|
Elcatonin Acetate |
60731-46-6 |
|
3P05 |
Glucagon(1-29)(Human) |
16941-32-5 |
|
3P06 |
Gonadorelin Acetate |
71447-49-9 |
|
3P07 |
GHRP-2 Acetate |
158861-67-7 |
|
3P08 |
GHRP-6 Acetate |
87616-84-0 |
|
3P09 |
Hexarelin |
140703-51-1 |
|
3P10 |
Leuprolide |
53714-56-0 |
|
|
50-57-7 |
|
3P12 |
Melanotan Ц |
|
|
3P13 |
Nesiritide--Acetate (BNP-32) |
114471-18-0 |
|
3P14 |
Octreotide Acetate |
|
|
|
|
50-56-6 |
|
3P16 |
Ornipressin Acetate |
3397-23-7 |
|
3P17 |
Pramlintide Acetate |
|
|
|
PT141 Acetate |
32780-32-8 |
|
3P19 |
Secretin Acetate |
17034-35-4 |
|
3P20 |
Thymosin α1 Acetate |
62304-98-7 |
|
3P21 |
Thymosin β4 Acetate |
77591-33-4 |
|
3P22 |
Triptorelin Acetate |
57773-63-4 |
|
3P23 |
Ziconotide Acetate |
107452-89-1 |
|
4P01 |
Allatostatin I |
C61H94N18O16 |
1335,53 |
|
4P02 |
Allatostatin II |
C44H66N12O7S2 |
939,22 |
|
4P03 |
Allatostatin III |
C42H61N11O8S2 |
912,15 |
|
5P01 |
Adrenomedullin (22-52), human |
C159H252N46O48 |
3576,03 |
|
5P02 |
Pro-Adrenomedullin N-20, rat |
C112H178N36O27 |
2460,87 |
|
6P01 |
Angiogenin Fragment (108-122) |
C78H125N25O23 |
1781,01 |
|
6P02 |
Angiogenin Fragment (108-123) |
C83H132N26O24 |
1878,12 |
|
6P03 |
Biotinyl-Angiotensin-I |
C72H103N19O16S |
1522,79 |
|
6P04 |
(Sar1,Gly8)-Angiotensin II |
C42H65N13O10 |
912,06 |
|
6P05 |
(Sar1,Ile8)-Angiotensin II |
C46H73N13O10 |
968,17 |
|
6P06 |
(Sar1,Tyr(Me)4)-Angiotensin II |
C50H73N13O10 |
1016,21 |
|
6P07 |
(Sar1,Ala8)-Angiotensin II |
C43H67N13O10 |
926,09 |
|
6P08 |
(Sar1,Ile4,8)-Angiotensin II |
C43H75N13O9 |
918,15 |
|
6P09 |
[Val4] Angiotensin III |
C46H66N12O9 |
931,11 |
|
6P10 |
[Val5] Angiotensin II, human |
C50H71N13O12 |
1046,19 |
|
7P01 |
Aldosterone-Secretion-Inhibiting Factor-(1-35)(bovine) |
C164H278N58O45S4 |
3910,64 |
|
7P02 |
mini-ANP |
C75H117N27O19S4 |
1829,19 |
|
7P03 |
Vasonatrin Peptide (VNP) |
C124H198N36O36S3 |
2865,36 |
|
7P04 |
Prepro-ANF(104-123),human |
C94H171N31O28 |
2183,58 |
|
7P05 |
Prepro-ANF (26-55), human |
C152H236N38O51S3 |
3507,97 |
|
8P01 |
Caerulein |
C58H73N13O21S2 |
1352,42 |
|
8P02 |
Caerulein--(desulfated) |
C58H73N13O18S |
1272,36 |
|
8P03 |
Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human) |
C43H53N7O9S |
844 |
|
9P01 |
Acetyl-Calpastatin (184-210) (human) |
C142H230N36O44S |
3177,67 |
|
9P02 |
Calpain Inhibitor I |
C20H37N3O4 |
383,53 |
|
9P03 |
Calpain-Inhibitor-II |
C19H35N3O4S |
401,57 |
|
9P04 |
Calpain Inhibitor III |
C22H26N2O4 |
382,46 |
|
10P01 |
Bradykinin |
C50H73N15O11 |
1060,22 |
|
10P02 |
Tyr-Bradykinin |
C59H82N16O13 |
1223,4 |
|
10P03 |
(Tyr8)-Bradykinin |
C50H73N15O12 |
1076,22 |
|
10P04 |
Bradykinin (1-3) |
C16H28N6O4 |
368,44 |
|
10P05 |
Bradykinin (1-7) |
C35H52N10O9 |
756,86 |
|
10P06 |
Lys-Bradykinin |
C56H85N17O12 |
1188,4 |
|
10P07 |
(D-Arg0,Hyp2,3,D-Phe7)Bradykinin |
C60H87N19O14 |
1298,47 |
|
10P08 |
(D-Arg0,Hyp3,D-Phe7,Leu8)-Bradykinin |
C57H89N19O13 |
1248,45 |
|
10P09 |
(Des-Arg9)-Bradykinin |
C50H69N15O11 |
1056,19 |
|
11P01 |
Calcitonin C-terminalAdjacent Peptide, rat |
C82H117N23O27S |
1889,04 |
|
11P02 |
Calcitonin (chicken) |
C145H240N42O46S2 |
3371,89 |
|
11P03 |
Calcitonin (eel) |
C146H241N43O47S2 |
3414,91 |
|
11P04 |
Calcitonin (8-32) (salmon I) |
C119H198N36O37 |
2725,1 |
|
11P05 |
Calcitonin-N-Terminal Flanking Peptide (human) |
C264H426N74O97S |
6220,79 |
|
11P06 |
Calcitonin (porcine) |
C159H232N46O45S3 |
3604,07 |
|
11P07 |
Calcitonin (rat) |
C148H228N40O46S3 |
3399,88 |
|
12P01 |
BAM-12P |
C62H97N21O16S |
1424,65 |
|
12P02 |
BAM-12P (7-12) |
C29H52N12O9 |
712,81 |
|
12P03 |
BAM-22P |
C130H184N38O31S2 |
2839,26 |
|
12P04 |
BAM-3200 |
C147H207N41O34S2 |
3156,65 |
|
13P01 |
β-Casomorphin (1-5), bovine |
C30H37N5O7 |
579,65 |
|
13P02 |
b-Casomorphin (bovine) |
C41H55N7O9 |
789,93 |
|
13P03 |
b-Casomorphin (1-4) amide (bovine) |
C28H35N5O5 |
521,62 |
|
13P04 |
(D-Ala2)-b-Casomorphin (1-4) amide (bovine) |
C26H33N5O5 |
495,58 |
|
13P05 |
(D-Pro2)-b-Casomorphin(1-5) (bovine) |
C30H37N5O7 |
579,65 |
|
14P0 |
Dynorphin A |
C99H155N31O23 |
2147,52 |
|
14P01 |
Dynorphin A (1-7) |
C40H61N13O9 |
868,01 |
|
14P02 |
Dynorphin A (1-9) |
C52H84N18O11 |
1137,35 |
|
14P03 |
(D-Ala2)-Dynorphin-A-(1-9) |
C53H86N18O11 |
1151,38 |
|
14P04 |
Dynorphin-A-(1-10) |
C57H91N19O12 |
1234,47 |
|
14P05 |
Dynorphin-A-(1-10) amide |
C57H92N20O11 |
1233,49 |
|
14P06 |
Dynorphin A (1-11) amide |
C63H104N22O12 |
1361,66 |
|
14P07 |
(D-Ala3)-Dynorphin A (1-11) amide |
C64H106N22O12 |
1375,69 |
|
14P08 |
Dynorphin-A-(1-13) |
C75H126N24O15 |
1603,98 |
|
15P01 |
(D-Ala2,D-Leu5)-Enkephalinv |
C29H39N5O7 |
569,66 |
|
15P02 |
(D-Ala2,D-Leu5)-Enkephalin amide |
C29H40N6O6 |
568,67 |
|
15P03 |
Leu-Enkephalin, amide |
C28H38N6O6 |
554,65 |
|
15P04 |
Leu-Enkephalin |
C28H37N5O7 |
555,63 |
|
15P05 |
Met-Enkephalin |
C27H35N5O7S |
573,67 |
|
15P06 |
Boc-Met-Enkephalin |
C32H43N5O9S |
673,79 |
|
15P07 |
Met-Enkephalin-Arg |
C33H47N9O8S |
729,86 |
|
15P08 |
(Gly0)-Met-Enkephalin |
C29H38N6O8S |
630,72 |
|
15P09 |
(Met(O)5)-Enkephalin |
C27H35N5O8S |
589,67 |
|
15P10 |
Met-Enkephalin-Arg-Lys |
C39H59N11O9S |
858,03 |
|
16P01 |
a-Endorphin |
C77H120N18O26S |
1745,97 |
|
16P02 |
b-Endorphin-(camel)
|
C155H250N42O44S |
3438 |
|
16P03 |
b-Endorphin-(equine) |
C154H248N42O44S |
3423,99 |
|
16P04 |
b-Endorphin-(human) |
C158H251N39O46S |
3465,03 |
|
16P05 |
b-Endorphin (18-31) (human) |
C75H122N20O20 |
1623,92 |
|
16P06 |
b-Endorphin (27-31) (human) |
C2 8H45N7O9 |
623,71 |
|
16P07 |
Acetyl-d-Endorphin |
C138H217N35O40S |
3038,52 |
|
17P01 |
Fibronectin Analog |
C29H51N11O11 |
729,79 |
|
17P02 |
G-R-A-D-S-P |
C23H39N9O10 |
601,62 |
|
17P03 |
G-R-G-D-N-P |
C23H38N10O10 |
614,62 |
|
17P04 |
G-R-G-D-S-P |
C22H37N9O10 |
587,59 |
|
17P05 |
Acetyl-(Tyr1,D-Arg2)-GRF(1-29)-amide-(human) |
C154H255N47O43S |
3485,08 |
|
17P06 |
(Nle27)-GRF (1-29) amide (human) |
C150H248N44O42 |
3339,89 |
|
18P01 |
Leucokinin I |
C41H53N11O12 |
891,94 |
|
18P02 |
Leucokinin II |
C39H50N10O12 |
850,89 |
|
18P03 |
Leucokinin III |
C40H52N12O13 |
908,93 |
|
19P01 |
a-MSH,-Free--Acid |
C77H108N20O20S |
1665,89 |
|
19P02 |
a-MSH,-human |
C118H174N34O35S |
2660,95 |
|
19P03 |
MSH,-porcine |
C98H138N26O29S |
2176,4 |
|
19P04 |
Acetyl-a-MSH-(11-13)
|
C18H33N5O4 |
383,49 |
|
20P01 |
Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe |
C50H82N10O14 |
1047,26 |
|
20P02 |
H-Glu-Val-Asp-Pro-Ile-Gly-His-Leu-Tyr-OH |
C48H71N11O15 |
1042,16 |
|
20P03 |
Mage-1 (161-169), human |
C41H57N11O17 |
975,97 |
|
20P04 |
[MAGE-3-Antigen (271-279)],human |
C53H79N13O10 |
1058,29 |
|
20P05 |
Neuromedin (U-8), porcine |
C54H78N16O10 |
1111,32 |
|
20P06 |
Neuromedin B |
C52H73N15O12S |
1132,31 |
|
20P07 |
(Tyr0)-Neurokinin A |
C59H89N15O16S |
1296,51 |
|
20P08 |
(Nle10)-Neurokinin A (4-10) |
C35H56N8O10 |
748,88 |
|
20P09 |
(Trp7,b-Ala8)-Neurokinin A (4-10) |
C41H57N9O10S |
868,02 |
|
21P01 |
Neurotensin (8-13) |
C38H64N12O8 |
817 |
|
21P02 |
Neurotensin (8-13), N-Acetyl |
C40H66N12O9 |
859,04 |
|
22P01 |
pTH (1-31) (human) |
C162H269N49O47S2 |
3719,35 |
|
22P02 |
pTH (1-31) amide (human) |
C162H270N50O46S2 |
3718,37 |
|
22P03 |
pTH (1-34) (human) |
C181H291N55O51S2 |
4117,77 |
|
22P04 |
pTH (1-34) amide (human) |
C181H292N56O50S2 |
4116,79 |
|
22P05 |
pTH(1-34)-(rat) |
C180H291N55O48S2 |
4057,76 |
|
22P06 |
pTH(29-32)-(human) |
C20H31N7O8 |
497,51 |
|
22P07 |
pTH-Related Protein (1-40) (human, rat) |
C207H334N66O58 |
4675,34 |
|
23P01 |
Peptide-YY-(human) |
C194H295N55O57 |
4309,81 |
|
23P02 |
(Leu31,Pro34)-PeptideYY-(human) |
C195H296N54O56 |
4292,83 |
|
23P03 |
Peptide YY (3-36)(dog, mouse, porcine, rat) |
C176H272N52O54 |
3980,41 |
|
23P04 |
Peptide YY (3-36) (human) |
C180H279N53O54 |
4049,52 |
|
23P05 |
Peptide YY (13-36)(porcine, rat |
C135H209N41O38 |
3014,4 |
|
23P06 |
Peptide YY (porcine,rat) |
C190H288N54O57 |
4240,71 |
|
23P07 |
(Pro34)-Peptide YY (human) |
C194H294N54O56 |
4278,8 |
|
24P0 |
Substance P |
C63H98N18O13S |
1347,65 |
|
24P01 |
Substance P (1-7) |
C41H65N13O10 |
900,05 |
|
24P02 |
Substance P (1-9) |
C52H77N15O12 |
1104,28 |
|
24P03 |
Substance-P-(2-11)Deca-Substance P |
C57H86N14O12S |
1191,46 |
|
24P04 |
Substance-P-(4-11)Octa-Substance P |
C46H67N11O10S |
966,17 |
|
24P05 |
Substance-P-(5-11) Hepta-Substance P |
C41H60N10O9S |
869,06 |
|
24P06 |
Substance-P-(-6-11) Hexa-Substance P |
C36H52N8O7S |
740,92 |
|
24P07 |
Substance-P,-Free-Acid |
C63H97N17O14S |
1348,64 |
|
24P08 |
(Tyr8)-Substance-P |
C63H98N18O14S |
1363,65 |
|
24P09 |
(Pyr5)-Substance-P-(5-11) |
C41H57N9O9S |
852,03 |
|
24P10 |
(Pyr5,N-Me-Phe8,Sar9)-Substance P (5-11) |
C43H61N9O15S |
895,09 |
|
24P11 |
(Pyr6,Pro9)-Substance P (6-11) |
C39H53N7O7S |
763,96 |
| |
|
Custom Peptide Synthesis Price List |
|
|
| |
|
Price/Residue for 6-30 mer peptide |
|
|
|
Quantity |
Crude |
Desalted |
>75% |
>85% |
>90% |
>95% |
>98% |
|
1-4mg |
156 |
158 |
163 |
167 |
171 |
172 |
183 |
|
5-9mg |
157 |
159 |
165 |
170 |
174 |
176 |
189 |
|
10-14mg |
158 |
161 |
168 |
174 |
178 |
181 |
196 |
|
15-19mg |
159 |
161 |
169 |
176 |
181 |
184 |
201 |
|
20-24mg |
159 |
161 |
172 |
179 |
184 |
189 |
208 |
|
25-29mg |
160 |
162 |
174 |
181 |
186 |
192 |
213 |
|
30-39mg |
160 |
163 |
176 |
183 |
189 |
195 |
217 |
|
40-49mg |
162 |
164 |
177 |
185 |
191 |
198 |
222 |
|
50-59mg |
162 |
164 |
181 |
188 |
195 |
201 |
226 |
|
60-79mg |
164 |
167 |
186 |
193 |
201 |
208 |
237 |
|
80-100mg |
165 |
167 |
193 |
201 |
211 |
218 |
252 |
|
1000mg |
204 |
206 |
278 |
303 |
334 |
354 |
456 |
|
